As of 2025-05-23, the Intrinsic Value of Maccura Biotechnology Co Ltd (300463.SZ) is 7.93 CNY. This 300463.SZ valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 11.70 CNY, the upside of Maccura Biotechnology Co Ltd is -32.30%.
The range of the Intrinsic Value is 4.57 - 22.91 CNY
Based on its market price of 11.70 CNY and our intrinsic valuation, Maccura Biotechnology Co Ltd (300463.SZ) is overvalued by 32.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 4.57 - 22.91 | 7.93 | -32.3% |
| DCF (Growth 10y) | 6.54 - 29.84 | 10.84 | -7.4% |
| DCF (EBITDA 5y) | 18.46 - 32.09 | 23.74 | 102.9% |
| DCF (EBITDA 10y) | 19.84 - 37.80 | 26.68 | 128.1% |
| Fair Value | 0.25 - 0.25 | 0.25 | -97.88% |
| P/E | 1.19 - 8.46 | 4.05 | -65.4% |
| EV/EBITDA | 0.66 - 15.58 | 7.15 | -38.9% |
| EPV | 1.39 - 2.07 | 1.73 | -85.2% |
| DDM - Stable | 0.53 - 2.90 | 1.71 | -85.4% |
| DDM - Multi | 13.97 - 43.99 | 19.78 | 69.0% |
| Market Cap (mil) | 7,165.90 |
| Beta | 1.35 |
| Outstanding shares (mil) | 612.47 |
| Enterprise Value (mil) | 7,288.54 |
| Market risk premium | 6.13% |
| Cost of Equity | 8.04% |
| Cost of Debt | 5.00% |
| WACC | 7.70% |